neno_ps

Embed Size (px)

Citation preview

  • 7/30/2019 neno_ps

    1/47

    Neonatal Sepsis and Recent

    Challenges

    Mohammad Khasswneh, MD

    Assistant Professor of PediatricsJUST

  • 7/30/2019 neno_ps

    2/47

  • 7/30/2019 neno_ps

    3/47

    introduction

    Common 20% of VLBW has sepsis In term 0.1%

    Inter-institution difference 11-32% (NICHD net work)

    Serious mortality is 3-5 times more for infant with sepsis in NICU

  • 7/30/2019 neno_ps

    4/47

    Classification

    Early onset sepsis (EOS):

    bacteria acquired before and during delivery

    5-7/1000 live birth 1.5% of VLBW infants had EOS (intrapartum antibiotics)

    Late onset sepsis (LOS):

    bacteria acquired after delivery (Nosocomialor community)

    20% of VLBW infants

  • 7/30/2019 neno_ps

    5/47

    Who is the septic

    neonate? Positive blood culture with clinical

    symptoms of infection

    Coagulase-negative Staphylococcus (CoNS)

    2 positive blood cultures

    One positive blood culture and elevated CRP

    Clinical sepsis or probable sepsis

  • 7/30/2019 neno_ps

    6/47

    Adult and Pediatrics

    Definitions

    Systemic Inflammatory response

    syndrome (SIRS) Sepsis

    as SIRS plus infection

    Severe sepsis: as sepsis associated with organ dysfunction,

    hypo perfusion or hypotension, Septic shock

    sepsis with arterial hypotension despite fluidresuscitation

  • 7/30/2019 neno_ps

    7/47

    Blood CultureOne out of five evaluations for

    sepsis has positive bloodculture

    80% of the time, empiric

    antibiotics will be given when noorganism is isolated fromculture

  • 7/30/2019 neno_ps

    8/47

    Blood culture

    In a 1999, autopsy study of ELBW

    infants infection was primary cause of death

    by pathologists in (56 of 111)

    sepsis was not diagnosed prior todeath for 61% of these 56 neonates

  • 7/30/2019 neno_ps

    9/47

    False negative Blood

    Culture Maternal antibiotics

    Small blood sample

    in a prospective study of nearly 300 blood

    cultures drawn from critically ill neonates,

    55% of culture vials contained less than 0.5

    ml of blood Bacteria load, timing of sampling

  • 7/30/2019 neno_ps

    10/47

    Diagnosis

  • 7/30/2019 neno_ps

    11/47

    Clinical Signs

    according to WHO Integrated Management of

    Childhood illness

    Respiratory rate >60 breaths/min

    Retraction, flaring, Grunting

    Crepitation

    Cyanosis

  • 7/30/2019 neno_ps

    12/47

    Clinical Sings

    according to WHO Integrated Management of

    Childhood illness

    Temperature >37.7C (or feels hot) or

  • 7/30/2019 neno_ps

    13/47

    Other signs in NICU

    abnormal heart rate characteristics Reduced digital capillary refill time

    metabolic acidosis

    Increase in weight

  • 7/30/2019 neno_ps

    14/47

    Clinical signs of sepsis

    in VLBW infants

    NICHD network study

    Apnea in 55%

    gastrointestinal problems (46%), increased need for oxygen or ventilatory

    support 36%

    lethargy/hypotonia 23%

    Hypotension 5%

    The positive predictive value 14 to 20%.

  • 7/30/2019 neno_ps

    15/47

    New Diagnostic Methods

    CRP

    Interleukin 6,8 IgM

    Polymerase chain reaction (PCR)

    DNA microarray technology Immunoassay

  • 7/30/2019 neno_ps

    16/47

    CRP

    Best discriminatory value for predicting

    septicemia Expressed by all gestational age

    sensitivity 48 to 63%

  • 7/30/2019 neno_ps

    17/47

    Serial CRP

    elevated CRP on day 1

    and/or day 2, identify most

    case of sepsis

    sensitivity (90.2%)

  • 7/30/2019 neno_ps

    18/47

    Serial CRP

    When CRP is normal on days 1

    and 2 ,neonatal sepsis can be

    confidently excluded andantibiotic therapy ceased

    negative predictive value

    (97.7%).

  • 7/30/2019 neno_ps

    19/47

    CRP

    Sensitivity of serial CRP

    testing is lower for

    bacteremia due to gram-

    positive than to gram-

    negative bacteria

  • 7/30/2019 neno_ps

    20/47

    CRP

    Help in timing of discontinuation

    of antibiotics when CRPnormalize

    Further studies is needed

  • 7/30/2019 neno_ps

    21/47

    Polymerase Chain

    Reaction (PCR)

    PCR: under investigation for

    bacterial and fungal infection

    amplification of16S rRNA,

    a gene universally present in

    bacteria but absent in humans

    Results in 9 h of sample acquisition

  • 7/30/2019 neno_ps

    22/47

    PCR

    Sensitivity 96%Specificity 99.4%

    positive predictive value 88.9%

    negative predictive value 99.8%

  • 7/30/2019 neno_ps

    23/47

    Microbiology in

    Developing Country Gram negative organisms

    Klebsiella, Escherichia coli,

    Pseudomonas, and Salmonella.

    Gram positive less common

    Staphylococcus Aureus

    Coagulase negative staphylococci (CONS) Streptococcus pneumoniae, and

    Streptococcus pyogenes

  • 7/30/2019 neno_ps

    24/47

    Microbiology In

    Developing Country

    Group B streptococcus (GBS) is rare

    Maternal recto-vaginal Carriage rates

    for GBS is similar to that in developed

    country

  • 7/30/2019 neno_ps

    25/47

    Meningitis

    developing country 1st week mainly Gram negative.

    Older than 1 week:Streptococcus pneumonia, 50% of

    all bacterial meningitis occurring

    between 7 and 90 days of age

    Fatality rate of 53%.

  • 7/30/2019 neno_ps

    26/47

    Microbiology in Developed

    Country EOS

    GBS and E coli

    Recently decrease in Gram positive organisms (GBS)and increase in Gram negative organisms

    LOS:

    Coagulase Negative Staph (CON),

    GBS

    Staph Aureus.

  • 7/30/2019 neno_ps

    27/47

    New trends

    incidence of GBS sepsis decreasedfrom 5.9 to 1.7 per 1,000

    the incidence of sepsis from E. coli

    increased from 3.2 to 6.8 per 1,000between 1991-1993 and 1998-2000

  • 7/30/2019 neno_ps

    28/47

    Case Fatality

    EOS: more severe and casefatality rate is higher( all-causes

    mortality was 37%)

    LOS: less sever (CoNS) 18%.

  • 7/30/2019 neno_ps

    29/47

    Mortality Per Organisms

    percentages/ LBW infants

    Gram-negative 257cases (36%)

    E coli 53 cases (34%) Klebsiella 62 cases (22%)

    Pseudomonas 43 cases (74%)

    Enterobacter 41 cases (26%)

    Serratia 39 cases (35%)

    fungal 151cases (31%)

  • 7/30/2019 neno_ps

    30/47

    Mortality Rate by Organisms in

    low birth weight infants

    Gram-positive 905 case 101 deaths (11.2%) CoNS . 606 cases (9.1%)

    S aureus 99 cases (17.2%)

    GBS 32 cases (21.9%)

    All other streptococci 65 cases (10.8%)

  • 7/30/2019 neno_ps

    31/47

    Sepsis Risk Factors

    Prematurity

    Birth weight

    Term 0.1%

    1,000 -1,500 g 10%

  • 7/30/2019 neno_ps

    32/47

    Frequent

    BloodDrawing??

  • 7/30/2019 neno_ps

    33/47

    Group B streptococcus

    (GBS)

    Maternal colonization 15 to 40% 50% of infants acquire surface

    colonization at delivery

    1% of colonized full-term infants developEONS

  • 7/30/2019 neno_ps

    34/47

    GBS

    In 1996, GBS guidelines

    Incidence declined from 5.9-1.7 per

    1,000 in 1992 and 1999 respectively

    Emergence of penicillin resistance

    among GBS (Japan)

  • 7/30/2019 neno_ps

    35/47

    GBS Guideline

    the incidence of infections with

    gram-negative bacteria increased

    antibiotic resistance among

    gram-negative pathogens hasincreased

  • 7/30/2019 neno_ps

    36/47

    Coagulase-Negative

    Staphylococci

    commonest cause of nosocomial

    bacteremiaventriculoperitoneal shunt infection

    Endocarditis with umbilical lines

    S. epidermidis, S. haemolyticus, S.

    hominis, S. saprophyticus,

  • 7/30/2019 neno_ps

    37/47

    Coagulase-NegativeStaphylococci

    Sepsis with CoNS is often

    indolent

    nonspecific symptoms

  • 7/30/2019 neno_ps

    38/47

    Coagulase-negativestaphylococc i

    a positive blood culture for CoNS mayrepresent either contamination

    26 cases, in only 16 cases were cultures

    from two sites positive, and the other 10cases were considered to represent

    contamination

  • 7/30/2019 neno_ps

    39/47

    Coagulase-negative

    staphylococc i

    Studies have shown that initial

    therapy of suspected LONS withnafcillin oroxacillin and an

    aminoglycoside,rather than

    vancomycin did not changeoutcome (decrease resistance)

  • 7/30/2019 neno_ps

    40/47

    Staphylococcus aureus

    Less commonly seen

    S. aureus strains remainedsensitive to extended-

    spectrum penicillins(oxacillin or nafcillin)

  • 7/30/2019 neno_ps

    41/47

    Gram Negative bacteria

    Klebsiella pneumoniae in our area

    E. coliin united states Increase in incidence

    Multiresistance

    Invasion of CNS, Citrobacter koseri

  • 7/30/2019 neno_ps

    42/47

    Gram Negative

    P. aeruginosa

    conjunctivitis

    systemic disease high mortality

    Haemophilus influenzae.

    Non typeable

    Fulminant, simulating RDS.

    Mortality 90%

  • 7/30/2019 neno_ps

    43/47

    Antibiotics

    Resistance

    Induced by antibiotic pressure

    (over use)

    Broad-spectrum cephalosporin

    induce chromosomal ESBLs ingram-negative bacilli

  • 7/30/2019 neno_ps

    44/47

    Antibiotics

    Resistance

    Ampicillin and Amikacin for empiric

    treatment of EONS Oxacillin and amikacin for empiric

    treatment of LONS reduce

    colonization with resistant gram-negative bacilli from 32 to 11%

  • 7/30/2019 neno_ps

    45/47

    Practical points

    LP should be done in evaluation of sepsis

    even with negative blood culture Urine culture is not part of work up for

    EOS

    Vesicoureteral reflux was present in 14%of VLBW infants with UTI.

  • 7/30/2019 neno_ps

    46/47

    Conclusions

    Gram negative organism is becoming

    more common worldwide GBS is not common in our area

    Multi-resistance organism mandate

    different approaches for N. sepsistreatment

  • 7/30/2019 neno_ps

    47/47

    Conclusions

    CRP can help in early discontinuation of

    antibiotics New Diagnostic Technology will play role

    in both

    Early diagnosis and treatment Restrict antibiotics over use